Sequana Medical Past Earnings Performance
Past criteria checks 0/6
Sequana Medical's earnings have been declining at an average annual rate of -18.4%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been declining at an average rate of 8.1% per year.
Key information
-18.4%
Earnings growth rate
1.3%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | -8.1% |
| Return on equity | n/a |
| Net Margin | -4,572.4% |
| Next Earnings Update | 19 Sep 2024 |
Revenue & Expenses BreakdownBeta
How Sequana Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -33 | 26 | 4 |
| 30 Sep 23 | 1 | -32 | 27 | 4 |
| 30 Jun 23 | 1 | -32 | 27 | 4 |
| 31 Mar 23 | 1 | -32 | 26 | 4 |
| 31 Dec 22 | 1 | -31 | 25 | 4 |
| 30 Sep 22 | 1 | -29 | 24 | 4 |
| 30 Jun 22 | 1 | -27 | 23 | 3 |
| 31 Mar 22 | 1 | -25 | 22 | 3 |
| 31 Dec 21 | 0 | -24 | 21 | 3 |
| 30 Sep 21 | 0 | -23 | 19 | 3 |
| 30 Jun 21 | 0 | -21 | 18 | 3 |
| 31 Mar 21 | 1 | -20 | 17 | 2 |
| 31 Dec 20 | 1 | -19 | 17 | 2 |
| 30 Sep 20 | 1 | -18 | 16 | 2 |
| 30 Jun 20 | 1 | -17 | 16 | 1 |
| 31 Mar 20 | 1 | -16 | 15 | 1 |
| 31 Dec 19 | 1 | -15 | 14 | 1 |
| 30 Sep 19 | 1 | -16 | 12 | 2 |
| 30 Jun 19 | 1 | -16 | 12 | 2 |
| 31 Mar 19 | 1 | -15 | 11 | 2 |
| 31 Dec 18 | 1 | -14 | 10 | 2 |
| 30 Sep 18 | 1 | -10 | 9 | 1 |
| 31 Dec 17 | 1 | -8 | 8 | 1 |
| 31 Dec 16 | 1 | -14 | 14 | 1 |
| 31 Dec 15 | 2 | -12 | 12 | 1 |
Quality Earnings: SEQUA is currently unprofitable.
Growing Profit Margin: SEQUA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SEQUA is unprofitable, and losses have increased over the past 5 years at a rate of 18.4% per year.
Accelerating Growth: Unable to compare SEQUA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SEQUA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).
Return on Equity
High ROE: SEQUA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.